IP Library Assignment 057044/0548
Patent Assignment
Reel/Frame 057044/0548

Change of Address

Recorded: 2021-07-26 Pages: 3
Assignor
EUTILEX CO., LTD.
Executed: 2021-07-26
Assignee
EUTILEX CO., LTD.
SUITE 408 ACE HANSOL TOWER, GASAN DIGITAL 1RO 58, GEUMCHEON-GU, SEOUL, 08591, KOREA, REPUBLIC OF
Covered Properties (17)
A Monoclonal Antibody Specifically Recognizing an Epitope for Switching to Th17 Cell
Patent: 9,309,321 →
Application: 13/861,619 →
Publication: US 2014/0072565
An Antibody Specifically Recognizing an Epitope for Switching to TH1 Cell
Patent: 9,255,151 →
Application: 13/861,644 →
Publication: US 2014/0065152
An Antibody Specifically Recognizing an Epitope for Switching to TH2 Cell and a Method for Converting T Cell to Type 2 Helper T Cell Using the Same
Patent: 9,255,152 →
Application: 13/861,675 →
Publication: US 2014/0072566
Monoclonal Antibody Which Specifically Recognizes B Cell Lymphoma and Use Thereof
Patent: 9,862,775 →
Application: 14/639,679 →
Publication: US 2016/0257762
Har-Nds-Derived Stem Cells, Method for Separating Same, and Use Thereof
Application: 15/307,820 →
Publication: US 2017/0173077
Methods for Isolating and Proliferating Autologous Cancer Antigen-Specific CD8+ T Cells
Application: 15/691,179 →
Publication: US 2018/0057793
Novel Epitope for Switching to TH17 Cell and Use Thereof
Application: 15/815,396 →
Publication: US 2018/0170997
Monoclonal Antibody Which Specifically Recognizes B Cell Lymphoma and Use Thereof
Application: 15/829,048 →
Publication: US 2018/0171026
Anti-Human 4-1BB Antibodies and Uses Thereof
Application: 15/863,526 →
Publication: US 2018/0258177
Novel Epitope for Switching to TH2 Cell and Use Thereof
Application: 15/866,061 →
Publication: US 2018/0371055
Methods for Isolating and Proliferating Autologous Cancer Antigen-Specific CD8+ T Cells
Application: 15/936,209 →
Publication: US 2018/0216066
Anti-Human 4-1BB Antibodies and Uses Thereof
Application: 16/191,381 →
Publication: US 2019/0071510
IFN-Gamma-Inducible Regulatory T Cell Convertible Anti-Cancer (IRTCA) Antibody and Uses Thereof
Application: 16/239,398 →
Publication: US 2019/0330358
IFN-Gamma-Inducible Regulatory T Cell Convertible Anti-Cancer (IRTCA) Antibody and Uses Thereof
Application: 16/255,690 →
Publication: US 2019/0233535
Chimeric Antigen Receptor That Binds Hla-Dr and Car-T Cell
Application: 16/715,462 →
Publication: US 2020/0237821
Anti-Human 4-1BB Antibodies and Uses Thereof
Application: 16/790,299 →
Publication: US 2020/0172626
Anti-Human VSIG4 Antibodies and Uses Thereof
Application: 16/838,887 →
Publication: US 2020/0291126
Related Assignments (24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 29, 2013
From: KWON, BYOUNG SE
To: NATIONAL CANCER CENTER
Reel/Frame 031123/0819 →
Assignment of Assignor's Interest Aug 29, 2013
From: KWON, BYOUNG SE
To: NATIONAL CANCER CENTER
Reel/Frame 031123/0807 →
Assignment of Assignor's Interest Sep 9, 2013
From: KWON, BYOUNG SE
To: NATIONAL CANCER CENTER
Reel/Frame 031189/0102 →
Assignment of Assignor's Interest May 19, 2015
From: KWON, BYOUNG SE; KIM, KWANG-HUI; KIM, YOUNG-HO; OH, HO-SIK
To: NATIONAL CANCER CENTER
Reel/Frame 035668/0821 →
Assignment of Assignor's Interest Oct 29, 2016
From: KWON, BYOUNG SE
To: EUTILEX CO., LTD
Reel/Frame 040164/0428 →
Assignment of Assignor's Interest Dec 27, 2016
From: PARK, INSOO; HAN, CHUNGYONG
To: NATIONAL CANCER CENTER
Reel/Frame 040775/0771 →
Nunc Pro Tunc Assignment Feb 9, 2017
From: NATIONAL CANCER CENTER
To: EUTILEX CO., LTD.
Reel/Frame 041215/0798 →
Assignment of Assignor's Interest Sep 5, 2017
From: KWON, BYOUNG SE; KANG, HYUN-GUY; KIM, KWANG-HUI; KIM, YOUNG-WOO
To: NATIONAL CANCER CENTER
Reel/Frame 043488/0597 →
Assignment of Assignor's Interest Jan 11, 2018
From: NATIONAL CANCER CENTER
To: EUTILEX CO., LTD.
Reel/Frame 044600/0798 →
License Jan 11, 2018
From: NATIONAL CANCER CENTER
To: EUTILEX CO., LTD.
Reel/Frame 044600/0698 →
Assignment of Assignor's Interest Jan 11, 2018
From: KWON, BYOUNG SE
To: NATIONAL CANCER CENTER
Reel/Frame 044600/0772 →
Assignment of Assignor's Interest Mar 26, 2018
From: KWON, BYOUNG S.; LEE, SEOUNG-JOO; KIM, YOUNG HO; OH, HO-SIK
To: EUTILEX CO., LTD.
Reel/Frame 045723/0374 →
Assignment of Assignor's Interest Jun 21, 2018
From: KWON, BYOUNG SE; KANG, HYUN-GUY; KIM, KWANG-HUI; KIM, YOUNG-WOO
To: NATIONAL CANCER CENTER
Reel/Frame 046165/0064 →
Assignment of Assignor's Interest Jun 21, 2018
From: NATIONAL CANCER CENTER
To: EUTILEX CO., LTD
Reel/Frame 046165/0110 →
Assignment of Assignor's Interest Sep 14, 2018
From: NATIONAL CANCER CENTER
To: EUTILEX CO., LTD.
Reel/Frame 047526/0120 →
Assignment of Assignor's Interest Sep 14, 2018
From: KWON, BYOUNG SE; KIM, KWANG-HUI; KIM, YOUNG-HO; OH, HO-SIK
To: NATIONAL CANCER CENTER
Reel/Frame 046880/0536 →
Assignment of Assignor's Interest Dec 13, 2019
From: KWON, BYOUNG S.; LEE, SEOUNG-JOO; LEE, JOONG WON; LEE, SEUNGHYUN
To: EUTILEX CO., LTD.
Reel/Frame 051272/0469 →
Nunc Pro Tunc Assignment Jun 17, 2020
From: NATIONAL CANCER CENTER
To: EUTILEX CO., LTD.
Reel/Frame 052967/0164 →
Assignment of Assignor's Interest Jun 17, 2020
From: KWON, BYOUNG SE
To: NATIONAL CANCER CENTER
Reel/Frame 052970/0772 →
Assignment of Assignor's Interest Jun 29, 2020
From: KWON, BYOUNG S.; LEE, SEOUNG-JOO; LEE, JOONG WON; LEE, SEUNGHYUN
To: EUTILEX CO., LTD.
Reel/Frame 053077/0683 →
Assignment of Assignor's Interest Jun 29, 2020
From: KWON, BYOUNG S.; LEE, SEOUNG-JOO; KIM, YOUNG HO; OH, HO-SIK
To: EUTILEX CO., LTD.
Reel/Frame 053076/0856 →
Assignment of Assignor's Interest Jan 18, 2021
From: KWON, BYOUNG S.; KIM, HYE JEONG; HWANG, SUNHEE; LEE, JOONGWON
To: EUTILEX CO., LTD.
Reel/Frame 054942/0344 →
Assignment of Assignor's Interest Apr 19, 2021
From: KWON, BYOUNG S.; KIM, YOUNG HO; KIM, KWANG HEE; CHUNG, JI WON
To: EUTILEX CO., LTD.
Reel/Frame 055963/0960 →
Corrective Assignment to Correct the Nature of Conveyance Previously Recorded on Reel 046165 Frame 0110. Assignor(S) Hereby Confirms the Exclusive License Agreement. Oct 10, 2022
From: NATIONAL CANCER CENTER
To: EUTILEX CO., LTD
Reel/Frame 062111/0907 →